CITATION RECORD // COMPONENT-ATTRIBUTED

KLOW Component Research: Full Reference List

Citations indexed by channel. DOI and PMID for every entry.

TB-500 / Thymosin beta-4 channel

Citations for the TB-500 and native thymosin beta-4 (Tbeta4) research arm. The critical distinction: most foundational efficacy data are for full-length native Tbeta4, not the short TB-500 (Ac-LKKTETQ) fragment.

[1] Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368. DOI: 10.1046/j.1523-1747.1999.00708.x. PMID: 10469335. https://pubmed.ncbi.nlm.nih.gov/10469335/

[7] Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. 2026. DOI: 10.1007/s40279-026-02437-0. PMID: 41966639. https://pubmed.ncbi.nlm.nih.gov/41966639/

BPC-157 channel

[2] Staresinic M, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21(6):976-983. DOI: 10.1016/s0736-0266(03)00110-4. PMID: 14554208. https://pubmed.ncbi.nlm.nih.gov/14554208/

[6] Lee E, Burgess K. Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. Altern Ther Health Med. 2025;31(5):20-24. PMID: 40131143. https://pubmed.ncbi.nlm.nih.gov/40131143/

[8] Sikiric P, et al. Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats. World J Gastroenterol. 2004;10(7):1032-1037. DOI: 10.3748/wjg.v10.i7.1032. PMID: 15052688. https://pubmed.ncbi.nlm.nih.gov/15052688/

[14] (Author group). Duodenocolic fistula healing by pentadecapeptide BPC 157 in rats. A cytoprotection viewpoint. J Physiol Pharmacol. 2024. DOI: 10.26402/jpp.2024.1.09. PMID: 38583442. https://pubmed.ncbi.nlm.nih.gov/38583442/

[15] Lee E, Walker C, Ayadi B. Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study. Altern Ther Health Med. 2024. PMID: 39325560. https://pubmed.ncbi.nlm.nih.gov/39325560/

KPV channel

[3] Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178. DOI: 10.1053/j.gastro.2007.10.026. PMID: 18061177. https://pubmed.ncbi.nlm.nih.gov/18061177/

[9] Kannengiesser K, Maaser C, Heidemann J, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis. 2008;14(3):324-331. DOI: 10.1002/ibd.20334. PMID: 18092346. https://pubmed.ncbi.nlm.nih.gov/18092346/

[10] Bettenworth D, Buyse M, Bohm M, et al. The tripeptide KdPT protects from intestinal inflammation and maintains intestinal barrier function. Am J Pathol. 2011;179(3):1230-1242. DOI: 10.1016/j.ajpath.2011.05.013. PMID: 21741932. https://pubmed.ncbi.nlm.nih.gov/21741932/

[11] Viennois E, Ingersoll SA, Ayyadurai S, et al. Critical Role of PepT1 in Promoting Colitis-Associated Cancer and Therapeutic Benefits of the Anti-inflammatory PepT1-Mediated Tripeptide KPV in a Murine Model. Cell Mol Gastroenterol Hepatol. 2016;2(3):340-357. DOI: 10.1016/j.jcmgh.2016.01.006. PMID: 27458604. https://pubmed.ncbi.nlm.nih.gov/27458604/

GHK-Cu channel

[4] Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108. DOI: 10.1155/2015/648108. PMID: 26236730. https://pmc.ncbi.nlm.nih.gov/articles/PMC4508379/

[5] Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987. DOI: 10.3390/ijms19071987. PMID: 29986520. https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/

[12] Sever'yanova LA, Dolgintsev ME. Effects of Tripeptide Gly-His-Lys in Pain-Induced Aggressive-Defensive Behavior in Rats. Bulletin of Experimental Biology and Medicine. 2017;164(2):140-143. DOI: 10.1007/s10517-017-3943-3. PMID: 29181666. https://pubmed.ncbi.nlm.nih.gov/29181666/

[13] Bobyntsev II, Chernysheva OI, Dolgintsev ME, Smakhtin MY, Belykh AE. Anxiolytic effects of Gly-His-Lys peptide and its analogs. Bulletin of Experimental Biology and Medicine. 2015;158(6):726-728. DOI: 10.1007/s10517-015-2847-3. PMID: 25900608. https://pubmed.ncbi.nlm.nih.gov/25900608/

  1. Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368.
  2. Staresinic M, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21(6):976-983.
  3. Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178.
  4. Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108.
  5. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987.
  6. Lee E, Burgess K. Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. Altern Ther Health Med. 2025;31(5):20-24.
  7. Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. 2026.
  8. Sikiric P, et al. Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats. World J Gastroenterol. 2004;10(7):1032-1037.
  9. Kannengiesser K, Maaser C, Heidemann J, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis. 2008;14(3):324-331.
  10. Bettenworth D, Buyse M, Bohm M, et al. The tripeptide KdPT protects from intestinal inflammation and maintains intestinal barrier function. Am J Pathol. 2011;179(3):1230-1242.
  11. Viennois E, Ingersoll SA, Ayyadurai S, et al. Critical Role of PepT1 in Promoting Colitis-Associated Cancer and Therapeutic Benefits of the Anti-inflammatory PepT1-Mediated Tripeptide KPV in a Murine Model. Cell Mol Gastroenterol Hepatol. 2016;2(3):340-357.
  12. Sever'yanova LA, Dolgintsev ME. Effects of Tripeptide Gly-His-Lys in Pain-Induced Aggressive-Defensive Behavior in Rats. Bulletin of Experimental Biology and Medicine. 2017;164(2):140-143.
  13. Bobyntsev II, Chernysheva OI, Dolgintsev ME, Smakhtin MY, Belykh AE. Anxiolytic effects of Gly-His-Lys peptide and its analogs. Bulletin of Experimental Biology and Medicine. 2015;158(6):726-728.
  14. Author group. Duodenocolic fistula healing by pentadecapeptide BPC 157 in rats. A cytoprotection viewpoint. J Physiol Pharmacol. 2024.
  15. Lee E, Walker C, Ayadi B. Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study. Altern Ther Health Med. 2024.